2024年12月16日 · Since our founding in 1934, we have been recognized for excellence in the national and international arenas of osteopathic physician testing and evaluation. We produce …

25I-NBOMe是一种 苯乙胺 类化合物衍生的致幻化合物。 属于2C-I家族。 由化学家 Ralf Heim于2003年在 柏林自由大学 首先发现 [1]。 是首个发现是5-HT2 受体 完全 激动剂 [2]。 25I …

COMLEX-USA assesses osteopathic medical knowledge, knowledge fluency, clinical skills, and other competencies essential for practice as an osteopathic generalist physician.

25I-NBOMe (2C-I-NBOMe, Cimbi-5, and also shortened to " 25I "), also known as Smiles, or N-Bomb, is a novel synthetic psychoactive substance with strong hallucinogenic properties, …

Passing COMLEX-USA Level 1 indicates that you have demonstrated competence in the foundational biomedical sciences and osteopathic principles and related physician …

The National Board of Osteopathic Medical Examiners (NBOME), founded in 1934 as the National Osteopathic Board of Examiners for Osteopathic Physicians and Surgeons, Inc., [1][2] is a …

NBOMe compounds are ultrapotent and highly efficacious agonists of serotonin 5-HT 2A and 5-HT 2C receptors (Ki values in low nanomolar range) with more than 1000-fold selectivity for 5 …

NBOMe 化合物是血清素 5-HT2A 和 5-HT2C 受体（低纳摩尔范围的 Ki 值）的超强效和高效激动剂，与 5-HT1A 相比，对 5-HT2A 的选择性超过 1000 倍。 与 5-HT2A 或 5-HT2C 相比，它们对 …

25B-NBOMe (NBOMe-2C-B, Cimbi-36, Nova, BOM 2-CB) is a derivative of the phenethylamine psychedelic 2C-B, discovered in 2004 by Ralf Heim at the Free University of Berlin.It acts as a …

麦斯卡林衍生物（2C 苯乙胺）药物通过引入 N-2-甲氧基苄基进行修饰，产生了一系列具有公认的有效致幻作用的新化合物，即 NBOMe 药物。 尽管它们在不受监管的药品市场上很普遍，但 …